Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.
Also called NCT01186120
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Registry
-
NCT01186120
-
- Other papers using this trial's data
- Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01186120. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions
- Acronym
- LONG-DES-V
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Biolimus A9-eluting stent
- Intervention (Device)
- Everolimus-eluting stent
- Lead sponsor
- Seung-Jung Park
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct01186120- Content hash
e0cf9795d46b92705fb204645f1f7e50570169d7384ff9e865635dc53b4ce776